UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 15, 2021 4:00 P.M.
Form: S-3
CIK: 0001341235
Company Name: Aldeyra Therapeutics, Inc.
File Number: 333-254175